SanaHeal

SanaHeal

Innovative bioadhesive solutions for rapid, robust, and blood-resistant tissue repair in clinical scenarios. Learn more
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

N/A

Seed
*
N/A

$2.3m

Grant
*

N/A

-
Total Funding€2.1m

Recent News about SanaHeal

Edit
More about SanaHealinfo icon
Edit

SanaHeal specializes in developing advanced bioadhesive technologies designed to address the challenges of rapid and effective tissue repair in various clinical scenarios. The company serves healthcare providers and medical institutions by offering bioadhesive patches and pastes that ensure rapid, robust, and blood-resistant sealing of tissue injuries. Operating in the medical devices market, SanaHeal's business model revolves around the development, production, and licensing of its proprietary bioadhesive technologies. The company generates revenue through the sale of its bioadhesive products and licensing agreements with medical institutions and healthcare providers. SanaHeal's products are engineered based on materials with a history of use in FDA-approved medical devices, ensuring high biosafety and tunable biodegradability. The company's innovations have been highlighted in prestigious publications and media outlets, reflecting its commitment to advancing medical technology.

Keywords: bioadhesive, tissue repair, medical devices, healthcare, clinical scenarios, biosafety, biodegradability, rapid sealing, blood-resistant, innovation.